跳至主要内容
临床试验/NCT07051109
NCT07051109招募中不适用

Comparison of Postoperative Recovery Between Dual-channel Pump for Intravenous Patient-controlled Analgesia(IV-PCA) and Conventional Single-channel Pump After Laparoscopic Sleeve Gastrectomy: a Prospective Randomized Controlled Trial

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2022年10月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
92
试验地点
1
主要终点
postoperative nausea and vomitting

研究概览

简要总结

Postoperative nausea and vomiting (PONV) are the most common complications that can occur after general anesthesia. Postoperative use of opioids and morbid obesity have been reported as risk factors of PONV. In this study, the investigators aimed to compare the degree of postoperative side effects and pain control when an intravenous patient-controlled analgesia combining fentanyl and ketorolac via a dual-chamber device was provided to participants undergoing laparoscopic sleeve gastrectomy.

详细描述

Morbidly obese patients undergoing laparoscopic sleeve gastrectomy experience a relatively high incidence of postoperative nausea and vomiting, but no effective treatment method has been established yet to prevent them. Through this study, the investigators can expect that if a dual-chamber patient-controlled analgesia device can provide effective analgesia while reducing the amount of opioid used, and thus reduce postoperative nausea and vomiting, it can have the effect of increasing the quality of recovery and satisfaction of participants who have undergone laparoscopic sleeve gastrectomy. Furthermore, this dual-chamber patient-controlled analgesia device can be applied to various surgeries and various patient groups who are at risk for postoperative nausea and vomiting, and it is expected that it can be adapted as one of the methods to prevent postoperative nausea and vomiting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Adult females aged 19 to 65 years
  • •American Society of Anesthesiologists physical status (ASA class) 1 to 3
  • •Patients scheduled for laparoscopic sleeve gastrectomy under general anesthesia
  • •Patients requesting the use of IV-PCA after surgery

排除标准

  • •Patients with hypersensitivity to the drugs used in this study (Ketorolac, Fentanyl)
  • •Patients with alcohol or drug dependence, long-term use of opioids or analgesics
  • •Patients with liver disease or renal failure
  • •Patients with peptic ulcer, patients with gastrointestinal bleeding predisposition
  • •Patients with suspected cerebrovascular hemorrhage, organic disorders of the head related to increased intracranial pressure
  • •Patients with bronchial asthma or bronchospasm symptoms
  • •Patients with severe respiratory depression
  • •Nasal polyps, angioedema
  • •Patients with or history of convulsive disease
  • •Patients for whom the use of neuromuscular blocking agents is contraindicated

研究组 & 干预措施

dual-chamber PCA

Experimental

干预措施: multimodal analgesia via dual-chamber PCA (Device)

single regimen PCA

Active Comparator

干预措施: single regimen (only fentanyl) (Device)

结局指标

主要结局

postoperative nausea and vomitting

时间窗: postoperative 1 day

The Quality of Recovery score 15

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Park InSun

Principal investigator

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验